NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
- Status
- RECRUITING
- Phase
- N/A
Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression
- Status
- WITHDRAWN
- Phase
- PHASE2
Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer
- Status
- WITHDRAWN
- Phase
- NA
ctDNA as a Biomarker for Treatment in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
- Status
- RECRUITING
- Phase
- NA
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
- Status
- RECRUITING
- Phase
- PHASE3
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
- Status
- UNKNOWN
- Phase
- N/A
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3